These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 4016788

  • 21. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL, Lauria F, Salvucci M, Rondelli D, Raspadori D, Bendandi M, Magagnoli M, Tura S.
    Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
    [Abstract] [Full Text] [Related]

  • 22. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS.
    J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia].
    Hofmann V, Scheel A, Schwarzmeier J, Talstad I, Varini M, Kaplan S, Sauter C, Fehr J.
    Schweiz Med Wochenschr; 1985 Feb 16; 115(7):235-8. PubMed ID: 3872477
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Berek JS, Hacker NF, Lichtenstein A, Jung T, Spina C, Knox RM, Brady J, Greene T, Ettinger LM, Lagasse LD.
    Cancer Res; 1985 Sep 16; 45(9):4447-53. PubMed ID: 4028027
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].
    Frey B, Hofmann V, Cavalli F, Fehr J, Kroner T, Nesthus I, Schwarzmeier J.
    Schweiz Med Wochenschr; 1988 Oct 15; 118(41):1468-75. PubMed ID: 3238389
    [Abstract] [Full Text] [Related]

  • 33. [Hairy cell leukemia achieved a complete remission after treatment with recombinant interferon-alpha: report of a case].
    Musashi M, Nakano M, Itasaka Y, Mitani R, Teng W, Kobayashi M, Saito N, Okabe M, Takemori N, Sakurada K.
    Rinsho Ketsueki; 1986 Mar 15; 27(3):391-7. PubMed ID: 3735688
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR, Hesdorffer CS, Dansey RD, Lewis D.
    S Afr Med J; 1987 Nov 21; 72(10):661-2. PubMed ID: 3686262
    [Abstract] [Full Text] [Related]

  • 35. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
    Abe Y, Sakai K, Igarashi T, Ishibashi T, Shiga T, Uchida T, Kariyone S.
    Rinsho Ketsueki; 1989 Apr 21; 30(4):535-40. PubMed ID: 2769975
    [Abstract] [Full Text] [Related]

  • 36. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB, Wolska-Smolen T, Blicharski J, Zduńczyk A, Sasiadek U, Pituch-Noworolska A.
    Cancer Detect Prev; 1988 Apr 21; 12(1-6):511-22. PubMed ID: 3180143
    [Abstract] [Full Text] [Related]

  • 37. [Recombinant interferon alpha 2 in treatment of hairy cell leukemia].
    Hasselbalch H, Hippe E, Lisse IM, Nielsen B, Ellegaard J, Jensen MK.
    Ugeskr Laeger; 1987 Aug 24; 149(35):2322-4. PubMed ID: 3451461
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of hairy cell leukemia with alpha-interferon and splenectomy.
    Tominaga S, Watanabe A, Higashi T, Hato S, Itoshima T, Hyodo I, Okushin H, Kita K, Nagashima H.
    J Med; 1987 Aug 24; 18(5-6):375-83. PubMed ID: 3505260
    [Abstract] [Full Text] [Related]

  • 39. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
    Steis RG, Smith JW, Urba WJ, Clark JW, Itri LM, Evans LM, Schoenberger C, Longo DL.
    N Engl J Med; 1988 Jun 02; 318(22):1409-13. PubMed ID: 3367950
    [Abstract] [Full Text] [Related]

  • 40. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL, Quesada JR, Baron S, Reuben J, Gutterman JU.
    Hematol Pathol; 1987 Jun 02; 1(3):157-65. PubMed ID: 3150846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.